ID   RHB1
AC   CVCL_RY57
DR   Wikidata; Q54950374
RX   CelloPub=CLPUB00423;
RX   PubMed=28889351;
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Cys135Gly (c.403T>G); ClinVar=VCV000376563; Zygosity=Unspecified (PubMed=28889351).
ST   Source(s): PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 31
ST   D5S818: 12,13
ST   D7S820: 7,12
ST   TH01: 9.3
ST   TPOX: 10
ST   vWA: 14
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 20-05-21; Version: 5
//
RX   CelloPub=CLPUB00423;
RA   Morrison B.J.;
RT   "Breast cancer stem cells: tumourspheres and implications for therapy.";
RL   Thesis PhD (2010), Griffith University, Australia.
//
RX   PubMed=28889351; DOI=10.1007/s10549-017-4496-x;
RA   Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L.,
RA   Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E.,
RA   Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J.,
RA   Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E.,
RA   Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F.,
RA   Lakhani S.R.;
RT   "Multidimensional phenotyping of breast cancer cell lines to guide
RT   preclinical research.";
RL   Breast Cancer Res. Treat. 167:289-301(2018).
//